A cluster randomized trial evaluating electronic prescribing in an ambulatory care setting

Merrick F Zwarenstein1, Katie N Dainty, Sherman Quan

  • 1Institute For Clinical Evaluative Sciences and The Clinical Epidemiology Unit, Center For Health Services Sciences, Sunnybrook Hospital, Ontario, Canada. merrick.zwarenstein@ices.on.ca

Trials
|October 5, 2007
PubMed
Summary

This pragmatic trial evaluated electronic prescribing to reduce medication errors. The study used a cluster randomized design in outpatient clinics, aiming to improve prescription safety and reduce adverse drug events.

Related Concept Videos

Methods of Documentation VII: EMR01:30

Methods of Documentation VII: EMR

Electronic Medical Records (EMRs) primarily center around electronically documenting patients' health information within a single healthcare organization or practice. They contain essential clinical data related to a patient's medical history, diagnoses, medications, treatment plans, lab results, and other pertinent information relevant to the specific encounter or episode of care. EMRs are designed to streamline documentation and workflow processes within individual healthcare settings,...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...